EverSource Wealth Advisors’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16K Sell
156
-23
-13% -$1.5K ﹤0.01% 2602
2026
Q1
$8.51K Buy
179
+120
+203% +$5.38K ﹤0.01% 3001
2025
Q4
$1.87K Sell
59
-109
-65% -$3.4K ﹤0.01% 3524
2025
Q3
$4.73K Sell
168
-241
-59% -$7.3K ﹤0.01% 3177
2025
Q2
$15K Buy
409
+45
+12% +$1.55K ﹤0.01% 2519
2025
Q1
$14.3K Buy
364
+291
+399% +$13.1K ﹤0.01% 1889
2024
Q4
$3.39K Buy
73
+18
+33% +$813 ﹤0.01% 2511
2024
Q3
$2.48K Buy
55
+35
+175% +$1.67K ﹤0.01% 2469
2024
Q2
$1.12K Buy
20
+18
+900% +$734 ﹤0.01% 2721
2024
Q1
$62 Sell
2
-498
-100% -$18K ﹤0.01% 2843
2023
Q4
$18.4K Hold
500
﹤0.01% 1271
2023
Q3
$10.1K Hold
500
﹤0.01% 1420
2023
Q2
$10.2K Hold
500
﹤0.01% 1429
2023
Q1
$7.54K Hold
500
﹤0.01% 1487
2022
Q4
$11.9K Hold
500
﹤0.01% 1263
2022
Q3
$18K Hold
500
﹤0.01% 941
2022
Q2
$17K Hold
500
﹤0.01% 883
2022
Q1
$25K Hold
500
0.01% 629
2021
Q4
$39K Buy
+500
New +$51.3K 0.01% 474

Other funds holding TWST

EverSource Wealth Advisors's TWST Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Twist Bioscience (TWST) stake by 13% in Q2 2026, selling an estimated $1.5K and leaving 156 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #2602.

EverSource Wealth Advisors first reported a position in TWST in Q4 2021 and has held it in 19 quarters since. The position peaked at $39K in Q4 2021. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • EverSource Wealth Advisors held 156 shares of Twist Bioscience worth $16K as of Q2 2026.
  • EverSource Wealth Advisors sold 23 Twist Bioscience shares in Q2 2026, an estimated $1.5K.
  • Twist Bioscience made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2602 holding.
  • EverSource Wealth Advisors first reported a position in Twist Bioscience in Q4 2021 and has held it in 19 quarters since.
  • EverSource Wealth Advisors's Twist Bioscience position peaked at $39K in Q4 2021.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.